| Michael J Picco, DO | |
|
2320 Freeway Drive, Mount Vernon, WA 98237 | |
| (360) 814-6800 | |
| (360) 814-6917 |
| Full Name | Michael J Picco |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 21 Years |
| Location | 2320 Freeway Drive, Mount Vernon, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194907337 | NPI | - | NPPES |
| 1088445 | Medicaid | WA | |
| 341377 | Other | WA | LABOR & INDUSTRIES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | OP00002317 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Skagit Valley Hospital | Mount vernon, WA | Hospital |
| Island Hospital | Anacortes, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Public Hospital Dist No 1 Skagit | 6800793522 | 248 |
News Archive
Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel - undetected by normal cells - through the bloodstream until activated by specific cancer proteins.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of its novel once-daily oral antibiotic Restanza to treat community acquired bacterial pneumonia (CABP). The trial is the first prospectively designed superiority study to be conducted in CABP.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
Geron Corporation announced today two grant awards to the University of Edinburgh from the UK Stem Cell Foundation, with funding from the Medical Research Council and Scottish Enterprise.
Children who receive solid organ transplants are hospitalized due to vaccine-preventable infections at rates that are significantly higher than the general population, according to a newly published study by University of Colorado School of Medicine researchers.
› Verified 5 days ago
| Entity Name | Public Hospital Dist No 1 Skagit |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023332749 PECOS PAC ID: 6800793522 Enrollment ID: O20040309001059 |
News Archive
Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel - undetected by normal cells - through the bloodstream until activated by specific cancer proteins.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of its novel once-daily oral antibiotic Restanza to treat community acquired bacterial pneumonia (CABP). The trial is the first prospectively designed superiority study to be conducted in CABP.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
Geron Corporation announced today two grant awards to the University of Edinburgh from the UK Stem Cell Foundation, with funding from the Medical Research Council and Scottish Enterprise.
Children who receive solid organ transplants are hospitalized due to vaccine-preventable infections at rates that are significantly higher than the general population, according to a newly published study by University of Colorado School of Medicine researchers.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael J Picco, DO 1400 E Kincaid St, Attn: Credentialing, Mount Vernon, WA 98274-4127 Ph: (360) 428-2500 | Michael J Picco, DO 2320 Freeway Drive, Mount Vernon, WA 98237 Ph: (360) 814-6800 |
News Archive
Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel - undetected by normal cells - through the bloodstream until activated by specific cancer proteins.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of its novel once-daily oral antibiotic Restanza to treat community acquired bacterial pneumonia (CABP). The trial is the first prospectively designed superiority study to be conducted in CABP.
A study published today in Age and Ageing, the scientific journal of the British Geriatrics Society, reports that the number of older people diagnosed with four or more diseases will double between 2015 and 2035. A third of these people will be diagnosed with dementia, depression or a cognitive impairment.
Geron Corporation announced today two grant awards to the University of Edinburgh from the UK Stem Cell Foundation, with funding from the Medical Research Council and Scottish Enterprise.
Children who receive solid organ transplants are hospitalized due to vaccine-preventable infections at rates that are significantly higher than the general population, according to a newly published study by University of Colorado School of Medicine researchers.
› Verified 5 days ago
Farouq A Al-hamdan, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 119 S 14th St, Mount Vernon, WA 98274 Phone: 713-553-3944 | |
David Michael Mourning, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2320 Freeway Dr, Mount Vernon, WA 98273 Phone: 360-814-6800 Fax: 360-814-6953 | |
Camille Lauren Connelly, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 Continental Pl, Mount Vernon, WA 98273 Phone: 360-424-7041 Fax: 360-424-2456 | |
Stacia Ann Smith, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1401 S Laventure Rd, Mount Vernon, WA 98274 Phone: 360-424-2400 Fax: 360-424-2418 | |
Dr. Michael Ge Thomas, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2320 Freeway Drive, Mount Vernon, WA 98273 Phone: 360-814-6800 Fax: 360-814-6917 | |
Robert M. Lipscomb, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2320 Freeway Dr, Mount Vernon, WA 98273 Phone: 360-814-6800 Fax: 360-814-6917 |